Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2026-03-09

Clinical Trial Update: Multidisciplinary Approach for Treat To Target In Rheumatoid Arthritis [NA]

View source ↗

Summary

This document notes that the clinical trial on a multidisciplinary, treat-to-target approach for rheumatoid arthritis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Conditions: Arthritis, Rheumatoid | NA | Status: WITHDRAWN